$INNV
InnovAge Holding Corp.

2021 Q2 Form 10-Q Financial Statement

#000155837021006838 Filed on May 11, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2021 Q1 2020 Q1
Revenue $171.6M $156.3M $144.8M
YoY Change 12.54% 7.97% 18.18%
Cost Of Revenue $123.6M $115.0M $110.3M
YoY Change 15.5% 4.26% 17.47%
Gross Profit $48.03M $41.40M $34.50M
YoY Change 5.57% 20.0% 20.63%
Gross Profit Margin 27.99% 26.49% 23.83%
Selling, General & Admin $34.33M $24.19M $18.66M
YoY Change 65.86% 29.65% 22.74%
% of Gross Profit 71.48% 58.42% 54.08%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.034M $3.311M $2.769M
YoY Change -47.23% 19.57% 38.45%
% of Gross Profit 6.32% 8.0% 8.03%
Operating Expenses $37.37M $24.19M $18.66M
YoY Change 50.67% 29.65% 6.0%
Operating Profit $10.67M -$5.366M $12.97M
YoY Change -48.46% -141.36% 17.95%
Interest Expense $274.0K $4.876M $2.361M
YoY Change -107.21% 106.52% -198.38%
% of Operating Profit 2.57% 18.2%
Other Income/Expense, Net -$15.00K -$9.760M -$2.117M
YoY Change -115.0% 361.03% 2017.0%
Pretax Income $10.93M -$15.10M $10.90M
YoY Change -35.34% -238.53% 28.24%
Income Tax $4.612M -$4.300M $2.900M
% Of Pretax Income 42.21% 26.61%
Net Earnings $6.474M -$10.51M $8.138M
YoY Change -46.5% -229.15% 31.26%
Net Earnings / Revenue 3.77% -6.72% 5.62%
Basic Earnings Per Share -$0.09 $0.06
Diluted Earnings Per Share $47.74K -$0.09 $0.06
COMMON SHARES
Basic Shares Outstanding 135.5M 121.3M 132.6M
Diluted Shares Outstanding 121.3M 134.4M

Balance Sheet

Concept 2021 Q2 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $201.5M $201.5M
YoY Change
Cash & Equivalents $201.5M $201.5M $96.13M
Short-Term Investments
Other Short-Term Assets $11.48M $5.800M
YoY Change
Inventory
Prepaid Expenses $9.249M
Receivables $32.58M $44.36M
Other Receivables $5.401M $100.0K
Total Short-Term Assets $250.9M $251.9M
YoY Change 50.32%
LONG-TERM ASSETS
Property, Plant & Equipment $142.7M $141.5M
YoY Change 39.24%
Goodwill $124.2M $124.2M
YoY Change 6.94%
Intangibles $6.518M
YoY Change 25.9%
Long-Term Investments $848.0K $3.500M
YoY Change
Other Assets $3.877M $3.600M
YoY Change
Total Long-Term Assets $280.8M $279.5M
YoY Change 15.71%
TOTAL ASSETS
Total Short-Term Assets $250.9M $251.9M
Total Long-Term Assets $280.8M $279.5M
Total Assets $531.8M $531.4M
YoY Change 29.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $32.36M $33.20M
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.790M $2.852M
YoY Change 95.56%
Total Short-Term Liabilities $78.57M $93.99M
YoY Change 2.52%
LONG-TERM LIABILITIES
Long-Term Debt $71.57M $72.42M
YoY Change -65.99%
Other Long-Term Liabilities $2.758M $2.390M
YoY Change 90.73%
Total Long-Term Liabilities $74.33M $74.81M
YoY Change -64.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $78.57M $93.99M
Total Long-Term Liabilities $74.33M $74.81M
Total Liabilities $173.8M $180.3M
YoY Change -42.43%
SHAREHOLDERS EQUITY
Retained Earnings $10.66M $4.820M
YoY Change -83.53%
Common Stock $136.0K $136.0K
YoY Change 2.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares $0.00 $0.00
Shareholders Equity $334.6M $328.1M
YoY Change
Total Liabilities & Shareholders Equity $531.8M $531.4M
YoY Change 29.81%

Cashflow Statement

Concept 2021 Q2 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $6.474M -$10.51M $8.138M
YoY Change -46.5% -229.15% 31.26%
Depreciation, Depletion And Amortization $3.034M $3.311M $2.769M
YoY Change -47.23% 19.57% 38.45%
Cash From Operating Activities $9.482M -$16.29M
YoY Change -68.8%
INVESTING ACTIVITIES
Capital Expenditures -$3.461M -$2.620M
YoY Change -24.6%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$3.461M -$2.620M
YoY Change -39.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $370.5M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.086M 143.7M
YoY Change -126.55%
NET CHANGE
Cash From Operating Activities 9.482M -16.29M
Cash From Investing Activities -3.461M -2.620M
Cash From Financing Activities -6.086M 143.7M
Net Change In Cash -65.00K 124.8M
YoY Change -100.14%
FREE CASH FLOW
Cash From Operating Activities $9.482M -$16.29M
Capital Expenditures -$3.461M -$2.620M
Free Cash Flow $12.94M -$13.67M
YoY Change -63.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001834376
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
132718461
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40159
dei Entity Registrant Name
EntityRegistrantName
InnovAge Holding Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-0710819
dei Entity Address Address Line1
EntityAddressAddressLine1
8950 E. Lowry Boulevard
dei Entity Address City Or Town
EntityAddressCityOrTown
Denver
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80230
dei City Area Code
CityAreaCode
844
dei Local Phone Number
LocalPhoneNumber
803-8745
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Trading Symbol
TradingSymbol
INNV
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
135516513
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
201527000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
112904000
CY2021Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
2236000
CY2020Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
1661000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7741000
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6384000
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
44356000
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
46312000
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3626000
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4311000
CY2021Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
131000
CY2020Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1743000
CY2021Q1 us-gaap Assets Current
AssetsCurrent
251876000
CY2020Q2 us-gaap Assets Current
AssetsCurrent
166931000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
141515000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
102494000
CY2021Q1 us-gaap Long Term Investments
LongTermInvestments
2645000
CY2020Q2 us-gaap Long Term Investments
LongTermInvestments
2645000
CY2021Q1 innv Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
3611000
CY2020Q2 innv Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
3003000
CY2021Q1 innv Equity Method Investment
EquityMethodInvestment
848000
CY2020Q2 innv Equity Method Investment
EquityMethodInvestment
13245000
CY2021Q1 us-gaap Goodwill
Goodwill
124217000
CY2020Q2 us-gaap Goodwill
Goodwill
116139000
CY2021Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
6683000
CY2020Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
5177000
CY2021Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
279519000
CY2020Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
242703000
CY2021Q1 us-gaap Assets
Assets
531395000
CY2020Q2 us-gaap Assets
Assets
409634000
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
33223000
CY2020Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
28875000
CY2021Q1 innv Reported And Estimated Claims Current
ReportedAndEstimatedClaimsCurrent
30735000
CY2020Q2 innv Reported And Estimated Claims Current
ReportedAndEstimatedClaimsCurrent
30291000
CY2021Q1 innv Due To State And Federal Health Programs
DueToStateAndFederalHealthPrograms
25054000
CY2020Q2 innv Due To State And Federal Health Programs
DueToStateAndFederalHealthPrograms
12244000
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
2852000
CY2020Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1938000
CY2021Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2121000
CY2020Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1496000
CY2020Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1789000
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
93985000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
76633000
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
5817000
CY2020Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
9282000
CY2021Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
5727000
CY2020Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
4091000
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2390000
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1446000
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
72415000
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
210432000
CY2021Q1 us-gaap Liabilities
Liabilities
180334000
CY2020Q2 us-gaap Liabilities
Liabilities
301884000
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
135516513
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
136000
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
133000
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
323127000
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
36338000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4820000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
64737000
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
0
CY2020Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
102030
CY2021Q1 us-gaap Interest Expense
InterestExpense
4876000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18595000
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14028000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
105901000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
42417000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3311000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2769000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9262000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8310000
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-163000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1343000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-203000
CY2021Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
19222000
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
0.0
CY2020 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
1.89
CY2020Q2 us-gaap Treasury Stock Value
TreasuryStockValue
193000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
328083000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
101015000
CY2021Q1 us-gaap Minority Interest
MinorityInterest
22978000
CY2020Q2 us-gaap Minority Interest
MinorityInterest
6735000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
351061000
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
107750000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
531395000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
409634000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
156308000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
144770000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
466184000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
414700000
CY2021Q1 innv External Provider Costs
ExternalProviderCosts
75389000
CY2020Q1 innv External Provider Costs
ExternalProviderCosts
71022000
innv External Provider Costs
ExternalProviderCosts
224215000
innv External Provider Costs
ExternalProviderCosts
204387000
CY2021Q1 us-gaap Direct Operating Costs
DirectOperatingCosts
39565000
CY2020Q1 us-gaap Direct Operating Costs
DirectOperatingCosts
39285000
us-gaap Direct Operating Costs
DirectOperatingCosts
115922000
us-gaap Direct Operating Costs
DirectOperatingCosts
114465000
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5592000
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4628000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14335000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14405000
CY2020Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-99000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
18211000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-250000
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
161674000
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
131796000
us-gaap Costs And Expenses
CostsAndExpenses
489189000
us-gaap Costs And Expenses
CostsAndExpenses
383937000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5366000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
12974000
us-gaap Operating Income Loss
OperatingIncomeLoss
-23005000
us-gaap Operating Income Loss
OperatingIncomeLoss
30763000
CY2020Q1 us-gaap Interest Expense
InterestExpense
2361000
us-gaap Interest Expense
InterestExpense
17061000
us-gaap Interest Expense
InterestExpense
11287000
CY2021Q1 innv Gain Loss On Extinguishment Of Debt Before Write Off Of Debt Issuance Cost
GainLossOnExtinguishmentOfDebtBeforeWriteOffOfDebtIssuanceCost
-13488000
innv Gain Loss On Extinguishment Of Debt Before Write Off Of Debt Issuance Cost
GainLossOnExtinguishmentOfDebtBeforeWriteOffOfDebtIssuanceCost
-14479000
CY2021Q1 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
10871000
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
10871000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2267000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
244000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2222000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-735000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9760000
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2117000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-22891000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12022000
CY2021Q1 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
-15126000
CY2020Q1 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
10857000
us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
-45896000
us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
18741000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4264000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2867000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5159000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4954000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-10862000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
7990000
us-gaap Profit Loss
ProfitLoss
-51055000
us-gaap Profit Loss
ProfitLoss
13787000
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-352000
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-148000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-595000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-394000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-10510000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
8138000
us-gaap Net Income Loss
NetIncomeLoss
-50460000
us-gaap Net Income Loss
NetIncomeLoss
14181000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
121324980
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132616431
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119619806
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132616431
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
121324980
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
134368002
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119619806
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
133792985
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4144000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3909000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9262000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8310000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
95636000
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
81442000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
407000
us-gaap Profit Loss
ProfitLoss
13787000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
95636000
us-gaap Profit Loss
ProfitLoss
-51055000
us-gaap Profit Loss
ProfitLoss
13787000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-2000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1021000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-31289000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
530000
CY2021Q1 innv Adjustments To Additional Paid In Capital Reclassification Of Warrant Liability
AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantLiability
2264000
CY2021Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
25334000
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
373580000
CY2021Q1 innv Noncontrolling Interest Increase From Consolidation Of Equity Method Investment
NoncontrollingInterestIncreaseFromConsolidationOfEquityMethodInvestment
16838000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-10862000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
351061000
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
107750000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
77603000
innv Stock Option Cancellation Value
StockOptionCancellationValue
9457000
innv Adjustments To Additional Paid In Capital Time Based Awards Option Cancelation
AdjustmentsToAdditionalPaidInCapitalTimeBasedAwardsOptionCancelation
32358000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1102000
innv Adjustments To Additional Paid In Capital Reclassification Of Warrant Liability
AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantLiability
2264000
innv Adjustments To Additional Paid In Capital Owners Contribution
AdjustmentsToAdditionalPaidInCapitalOwnersContribution
20000000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
25334000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
373580000
innv Noncontrolling Interest Increase From Consolidation Of Equity Method Investment
NoncontrollingInterestIncreaseFromConsolidationOfEquityMethodInvestment
16838000
us-gaap Profit Loss
ProfitLoss
-51055000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
351061000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
87511000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
135000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
7990000
innv Gain Loss On Consolidation
GainLossOnConsolidation
10871000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-8494000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
948000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
412000
us-gaap Share Based Compensation
ShareBasedCompensation
1102000
us-gaap Share Based Compensation
ShareBasedCompensation
407000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2264000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-3464000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
313000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1343000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-203000
innv Prepayment Penalty On Extinguishment Of Debt
PrepaymentPenaltyOnExtinguishmentOfDebt
6000000
innv Property And Equipment Included In Accounts Payable
PropertyAndEquipmentIncludedInAccountsPayable
224000
innv Fair Value Of Contingent Consideration
FairValueOfContingentConsideration
-250000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1402000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6929000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-635000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-274000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-1613000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-2562000
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
606000
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-689000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7717000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1372000
innv Increase Decrease In Reported And Estimated Claims
IncreaseDecreaseInReportedAndEstimatedClaims
114000
innv Increase Decrease In Reported And Estimated Claims
IncreaseDecreaseInReportedAndEstimatedClaims
-816000
innv Increase Decrease In Due To State And Federal Health Programs
IncreaseDecreaseInDueToStateAndFederalHealthPrograms
12732000
innv Increase Decrease In Due To State And Federal Health Programs
IncreaseDecreaseInDueToStateAndFederalHealthPrograms
-5245000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17028000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
20021000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14083000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9088000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
169000
innv Proceeds From Net Working Capital Settlements
ProceedsFromNetWorkingCapitalSettlements
1129000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16083000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7790000
us-gaap Payments Of Dividends
PaymentsOfDividends
9458000
us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
20000000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1685000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
850000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
375000000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
25000000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
512649000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1447000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
8896000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
373580000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
77603000
innv Payments Under Acquisition Agreement
PaymentsUnderAcquisitionAgreement
3622000
innv Payments Related To Option Cancelation
PaymentsRelatedToOptionCancelation
32358000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
122309000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22703000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
89198000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
34934000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
114565000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
61196000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
203763000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
96130000
us-gaap Interest Paid Net
InterestPaidNet
16251000
us-gaap Interest Paid Net
InterestPaidNet
10330000
us-gaap Income Taxes Paid
IncomeTaxesPaid
7047000
us-gaap Income Taxes Paid
IncomeTaxesPaid
2080000
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
42005000
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
32870000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
141515000
us-gaap Depreciation
Depreciation
7800000
us-gaap Depreciation
Depreciation
8800000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
102494000
innv Property And Equipment Purchased Under Capital Leases
PropertyAndEquipmentPurchasedUnderCapitalLeases
3517000
innv Property And Equipment Purchased Under Capital Leases
PropertyAndEquipmentPurchasedUnderCapitalLeases
1115000
CY2021Q1 dei Entity Number Of Employees
EntityNumberOfEmployees
2100
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
183520000
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
135364000
innv Percentage Of Revenue
PercentageOfRevenue
1
innv Percentage Of Revenue
PercentageOfRevenue
1
CY2021Q1 innv Fund Amount Received Covid19
FundAmountReceivedCovid19
2000000.0
CY2021Q1 innv Reimbursement Amount Allocated Covid19
ReimbursementAmountAllocatedCovid19
1000000.0
innv Reimbursement Amount Recognized Covid19
ReimbursementAmountRecognizedCovid19
700000
innv Reimbursement Amount Recognized Covid19
ReimbursementAmountRecognizedCovid19
300000
CY2020Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
22600000
CY2020Q3 us-gaap Dividends
Dividends
9500000
CY2021Q1 innv Number Of Equity Method Investments
NumberOfEquityMethodInvestments
2
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9000000.0
CY2019Q1 us-gaap Land
Land
4200000
CY2019Q1 us-gaap Business Acquisition Percentage Of Voting Interests Acquired
BusinessAcquisitionPercentageOfVotingInterestsAcquired
0.001
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2300000
CY2021Q1 us-gaap Business Acquisition Percentage Of Voting Interests Acquired
BusinessAcquisitionPercentageOfVotingInterestsAcquired
0.001
innv Gain Loss On Consolidation
GainLossOnConsolidation
10900000
CY2021Q1 us-gaap Goodwill
Goodwill
124200000
CY2020Q2 us-gaap Goodwill
Goodwill
116100000
CY2021Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
8100000
us-gaap Number Of Reporting Units
NumberOfReportingUnits
3
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6600000
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6600000
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1900000
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1400000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
200000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000
CY2020Q4 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2000000.0
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2021Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1400000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
3500000
CY2020Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1500000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
3800000
CY2021Q1 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
8962000
CY2021Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
30762000
CY2021Q1 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
1114000
CY2021Q1 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
7848000
CY2021Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
2121000
CY2021Q1 us-gaap Capital Leases Future Minimum Payments Remainder Of Fiscal Year
CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear
713000
CY2021Q1 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
866000
CY2021Q1 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
2527000
CY2021Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
4138000
CY2021Q1 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
2468000
CY2021Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
4410000
CY2021Q1 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
1941000
CY2021Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
4052000
CY2021Q1 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
1169000
CY2021Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
3592000
CY2021Q1 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
144000
CY2021Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
13704000
CY2021Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
5727000
CY2021Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
77377000
CY2020Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
215026000
CY2021Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
-2110000
CY2020Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
-2656000
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
2852000
CY2020Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1938000
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
72415000
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
210432000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2100000
CY2021Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
900000
CY2020Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
400000
CY2018Q3 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
30000000.0
CY2018Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
20000000.0
CY2018Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
20000000.0
CY2021Q1 innv Business Combination Contingent Consideration Paid
BusinessCombinationContingentConsiderationPaid
20000000.0
CY2021Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
0
CY2020Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1751571
us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.04
CY2021Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
400000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1300000
CY2020Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
400000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1300000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-10510000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
8138000
us-gaap Net Income Loss
NetIncomeLoss
-50460000
us-gaap Net Income Loss
NetIncomeLoss
14181000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
121324980
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132616431
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119619806
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132616431
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2021Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
11100000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
530000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
135000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
46489000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
407000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1176554
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
121324980
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
134368002
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119619806
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
133792985
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2020Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
16095819
CY2020Q3 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
4.82
CY2020Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
77600000
CY2021Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
0
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4300000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2900000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5200000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5000000.0
CY2021Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.282
CY2020Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.264
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.112
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.264
CY2021Q1 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
10871000
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
35000

Files In Submission

Name View Source Status
0001558370-21-006838-index-headers.html Edgar Link pending
0001558370-21-006838-index.html Edgar Link pending
0001558370-21-006838.txt Edgar Link pending
0001558370-21-006838-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmb-20210331.xsd Edgar Link pending
tmb-20210331x10q.htm Edgar Link pending
tmb-20210331x10q004.jpg Edgar Link pending
tmb-20210331x10q_htm.xml Edgar Link completed
tmb-20210331xex10d4.htm Edgar Link pending
tmb-20210331xex31d1.htm Edgar Link pending
tmb-20210331xex31d2.htm Edgar Link pending
tmb-20210331xex32d1.htm Edgar Link pending
tmb-20210331xex32d2.htm Edgar Link pending
tmb-20210331_cal.xml Edgar Link unprocessable
tmb-20210331_def.xml Edgar Link unprocessable
tmb-20210331_lab.xml Edgar Link unprocessable
tmb-20210331_pre.xml Edgar Link unprocessable